Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Insight Genetics Promotes Four

Published: Wednesday, February 13, 2013
Last Updated: Wednesday, February 13, 2013
Bookmark and Share
Molecular diagnostics company builds expertise and depth in research, application and commercial development of companion diagnostics to improve cancer care.

Insight Genetics has announced that it has promoted four of its team members:
• Brock Schweitzer, PhD, is now senior scientist;
• Rachel Skelton, PhD, was promoted to regulatory scientist I;
• Kasey Lawrence was named technology specialist; and
• JonEric Pettersson assumed a new role as manager of commercial development.

Since its founding in 2007, Insight Genetics has been dedicated to enabling precision medicine in cancer care. The company collaborates with researchers, clinicians, and drug developers to develop molecular diagnostics that aid physicians in precisely typing and effectively treating patients’ cancers.

“Brock, Rachel, Kasey and JonEric have brought a breadth of knowledge and expertise to Insight Genetics that has helped us consistently generate exceptional scientific results and inform our business development efforts,” said Christopher Callaghan, president and COO of Insight Genetics. “They have all made significant contributions to our company’s growth and been integral in advancing the field of personalized cancer care.”

Senior Scientist Schweitzer, who completed his post-doctoral research training in immune cell function at Vanderbilt University School of Medicine, plans and conducts laboratory research on Insight Genetics’ expanding array of diagnostic tests.

He also contributes to the company’s licensing of biomarkers and technologies, and supports planning and coordination of its academic, clinical and corporate partnerships.

Before joining Insight Genetics as scientist II in 2012, Schweitzer received his PhD in molecular genetics from University of Cincinnati College of Medicine.

As regulatory scientist I, Skelton works with clinicians, researchers and pharmaceutical companies to test patient samples for cancer-causing biomarkers within Insight Genetics’ CLIA-certified molecular diagnostic lab.

She also ensures scientific and regulatory compliance for all tests performed in the lab. Skelton joined Insight Genetics in July 2012 after receiving her PhD in cell and developmental biology from Vanderbilt University School of Medicine, where she became proficient in molecular diagnostics and genetic screening.

As a technology specialist, Lawrence oversees day-to-day operations and conducts research for clinical tests in development, while also managing data in the CLIA lab.

As in his previous role as research associate III, Lawrence will continue to use his research background to apply new techniques and technologies in the company’s diagnostic lab.

Prior to joining Insight Genetics, Lawrence worked as a research assistant at Vanderbilt University’s Division of Genetic Medicine and the Genome Sciences Resource. He holds a bachelor of science in biology from Tennessee Tech University.

Pettersson, as manager of commercial development, guides commercialization of the company’s products for cancer diagnosis and monitoring. He also will identify new diagnostic and partnership opportunities for Insight Genetics.

Pettersson joined Insight Genetics in 2007 and became the company’s senior associate of business development in 2011.

He holds a bachelor’s degree in business administration, with a focus on international business, from Belmont University.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Insight Genetics Announces Promotions for Two Team Members
Kasey Lawrence has been named Senior Technology Specialist, and Tyler Nielsen has been appointed Research Scientist.
Thursday, August 21, 2014
Insight Genetics and Vanderbilt-Ingram Cancer Center Partner
Research collaboration includes exclusive licensing agreement to commercialize a new genetic test that will improve treatment selection for breast cancer patients with poor prognosis.
Wednesday, March 05, 2014
Insight Genetics Awarded NCI Contract
Company receives Phase II Award to continue development of a companion diagnostic test for drugs targeting anaplastic lymphoma kinase.
Tuesday, January 07, 2014
Insight Genetics Launches Insight Molecular Labs
CLIA-certified laboratory offers diagnostic tests that identify specific cancer biomarkers.
Friday, December 13, 2013
Insight Genetics and National Cancer Institute Collaborate to Develop New Technologies for Clinical Trials
Insight Genetics has developed a diagnostic test that can more accurately determine if certain lung cancer patients will respond to targeted therapies.
Tuesday, April 02, 2013
Insight Genetics Awarded Qualifying Therapeutic Discovery Program Grant
Diagnostics Company Receives Funds to Advance Cancer Care.
Wednesday, November 17, 2010
Scientific News
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos